Expand HALO Menu
HALO MENU

HALO Stock Summary and Trading Ideas (Halozyme Therapeutics | NASDAQ:HALO)

Charts for Today's Stock Price and Implied Volatility in Halozyme Therapeutics

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for HALO by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Halozyme Therapeutics (HALO) Frequently Asked Questions

What does Halozyme Therapeutics do?

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

What symbol and exchange does Halozyme Therapeutics stock trade?

Halozyme Therapeutics trades on the NASDAQ stock market under the symbol HALO.

What is Halozyme Therapeutics stock price doing today?

As of April 19, 2024, HALO stock price climbed to $38.64 with 965,872 million shares trading.

What is Halozyme Therapeutics's Beta?

HALO has a beta of 1.21, meaning it tends to be more sensitive to market movements. HALO has a correlation of 0.20 to the broad based SPY ETF.

How much is Halozyme Therapeutics worth?

HALO has a market cap of $4.90 billion. This is considered a Mid Cap stock.

How much money does Halozyme Therapeutics make?

Last quarter Halozyme Therapeutics reported $230 million in Revenue and $.82 earnings per share. This fell short of revenue expectation by $-3 million and missed earnings estimates by -$.01.

What is the highest and lowest price Halozyme Therapeutics traded in the last 3 year period?

In the last 3 years, HALO stock traded as high as $59.46 and as low as $29.85.

What are the top ETFs holding Halozyme Therapeutics?

The top ETF exchange traded funds that HALO belongs to (by Net Assets): VTI, IJH, VB, IWM, VXF.

Is Halozyme Therapeutics (HALO) a good investment?

HALO stock has underperformed the market in the last year with a return of +8.2%, while SPY returned +21.2%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in HALO shares. However, HALO has outperformed the market in the last 3 month and 2 week periods, returning +10.6% and -2.7%, while SPY returned +4.3% and -3.5%, respectively. This indicates HALO has been having a stronger performance recently.

What is the support and resistance for Halozyme Therapeutics (HALO) stock price?

HALO support price is $37.10 and resistance is $38.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HALO stock will trade within this expected range on the day.